Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
50.44 USD | -3.69% | -3.76% | +27.80% |
05-08 | Earnings Flash (KROS) KEROS THERAPEUTICS Reports Q1 Revenue $83,000 | MT |
05-08 | Keros Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.80% | 1.89B | |
+8.33% | 115B | |
+13.00% | 107B | |
-13.57% | 22.31B | |
-3.99% | 21.6B | |
-5.79% | 18.23B | |
-39.93% | 17.62B | |
+7.35% | 14.26B | |
+33.65% | 12.37B | |
-27.99% | 8.28B |
- Stock Market
- Equities
- KROS Stock
- News Keros Therapeutics, Inc.
- BTIG Adjusts Price Target on Keros Therapeutics to $105 From $95, Maintains Buy Rating